All Stories

  1. Spatial Network Mapping of Pulmonary Multidrug-Resistant Tuberculosis Cavities Using RNA Sequencing

    Article • American Journal of Respiratory and Critical Care Medicine, August 2019, American Thoracic Society

    Dr Tawanda Gumbo

  2. Quantitative assessment of the activity of antituberculosis drugs and regimens

    Article • Expert Review of Anti-infective Therapy, May 2019, Taylor & Francis

    Gustavo Velásquez, Dr Tawanda Gumbo, DR Maxwell Tawanda Chirehwa

  3. Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis

    Article • American Journal of Respiratory and Critical Care Medicine, November 2018, American Thoracic Society

    Dr Tawanda Gumbo, Shashikant Srivastava

  4. Reply to Zimenkov, “Mutation in luxR Family Transcriptional Regulator Rv0890c Is Not a Marker of Linezolid Resistance”

    Article • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals

    Dr Tawanda Gumbo, Shashikant Srivastava

  5. Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, November 2017, ASM Journals

    Dr Tawanda Gumbo

  6. pH Conditions under Which Pyrazinamide Works in Humans

    Article • Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals

    Dr Tawanda Gumbo, Shashikant Srivastava

  7. Systematic Review and Meta-analyses of the Effect of Chemotherapy on Pulmonary Mycobacterium abscessus Outcomes and Disease Recurrence

    Article • Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals

    Dr Tawanda Gumbo, Shashikant Srivastava

  8. Supervised Machine-Learning Reveals That Old and Obese People Achieve Low Dapsone Concentrations

    Article • CPT Pharmacometrics & Systems Pharmacology, July 2017, Wiley

    Dr Tawanda Gumbo

  9. Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, June 2017, ASM Journals

    Dr Tawanda Gumbo

  10. Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, July 2016, ASM Journals

    Dr Tawanda Gumbo

  11. Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients

    Article • Antimicrobial Agents and Chemotherapy, July 2016, ASM Journals

    Dr Tawanda Gumbo

  12. Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection

    Article • Antimicrobial Agents and Chemotherapy, July 2016, ASM Journals

    Dr Tawanda Gumbo, Shashikant Srivastava

  13. Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases

    Article • Antimicrobial Agents and Chemotherapy, May 2016, ASM Journals

    Dr Tawanda Gumbo, Shashikant Srivastava

  14. Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease

    Article • Antimicrobial Agents and Chemotherapy, April 2016, ASM Journals

    Dr Tawanda Gumbo, Shashikant Srivastava

  15. Tigecycline Is Highly Efficacious against Mycobacterium abscessus Pulmonary Disease

    Article • Antimicrobial Agents and Chemotherapy, February 2016, ASM Journals

    Dr Tawanda Gumbo, Shashikant Srivastava